Multiple sclerosis (MS) patients who take disease-modifying therapies (DMTs) often get financial help from pharmaceutical company assistance programs, researchers found. However, about 6% of MS patients said they were not taking disease-modifying drugs because of insurance or financial concerns.
Trending:
Patients Get Financial Help With MS Drugs